106 related articles for article (PubMed ID: 32708076)
1. New Clue: Prediction from Cell-Free DNA.
Sanders YY
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708076
[TBL] [Abstract][Full Text] [Related]
2. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.
Yang JYC; Verleden SE; Zarinsefat A; Vanaudenaerde BM; Vos R; Verleden GM; Sarwal RD; Sigdel TK; Liberto JM; Damm I; Watson D; Sarwal MM
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30781765
[TBL] [Abstract][Full Text] [Related]
3. Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients.
Schneck E; Askevold I; Rath R; Hecker A; Reichert M; Guth S; Koch C; Sander M; Seeger W; Mayer K; Padberg W; Sommer N; Kuhnert S; Hecker M
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887906
[TBL] [Abstract][Full Text] [Related]
4. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
5. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
[TBL] [Abstract][Full Text] [Related]
6. Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant.
Trindade AJ; Chapin KC; Mullican A; Gray JN; Hoy H; Demarest CT; Lambright ES; McPherson KA; Norfolk SG; Robbins IM; Bacchetta M; Erasmus DB; Shaver CM
Transplant Direct; 2022 Dec; 8(12):e1411. PubMed ID: 36406896
[TBL] [Abstract][Full Text] [Related]
7. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
[TBL] [Abstract][Full Text] [Related]
8. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
[TBL] [Abstract][Full Text] [Related]
9. BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.
Vandermeulen E; Verleden SE; Ruttens D; Moelants E; Mortier A; Somers J; Bellon H; Piloni D; Dupont LJ; Van Raemdonck DE; Proost P; Schols D; Vos R; Verleden GM; Vanaudenaerde BM
Transpl Immunol; 2015 Sep; 33(1):37-44. PubMed ID: 26168736
[TBL] [Abstract][Full Text] [Related]
10. Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients.
Siddiqui AS; Kumar G; Majumdar T; Graviss EA; Nguyen DT; Goodarzi A; Kaleekal T
Clin Transplant; 2018 Oct; 32(10):e13397. PubMed ID: 30192029
[TBL] [Abstract][Full Text] [Related]
11. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
[TBL] [Abstract][Full Text] [Related]
12. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
[TBL] [Abstract][Full Text] [Related]
13. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
[TBL] [Abstract][Full Text] [Related]
15. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.
Van Herck A; Frick AE; Schaevers V; Vranckx A; Verbeken EK; Vanaudenaerde BM; Sacreas A; Heigl T; Neyrinck AP; Van Raemdonck D; Dupont LJ; Yserbyt J; Verleden SE; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Mar; 38(3):252-259. PubMed ID: 30686699
[TBL] [Abstract][Full Text] [Related]
17. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
[No Abstract] [Full Text] [Related]
18. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
19. Lung transplant recipients on long-term extracorporeal photopheresis.
Isenring B; Robinson C; Buergi U; Schuurmans MM; Kohler M; Huber LC; Benden C
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
[TBL] [Abstract][Full Text] [Related]
20. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
